Is CREATES Act Equipped To Handle Biosimilar Complaints?

Biosimilar sponsors need multiple reference product lots and expiration dates, and questions remain about whether they can obtain enough to fulfill all regulatory requirements under a CREATES Act mandate, Teva attorney says.

puzzle piece
The courts may be needed to fit biosimilar issues into the CREATES Act framework. • Source: Alamy

Biosimilar sponsors may find the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act, intended to ensure their access to reference product for testing, is not as clear as with conventional generics and that more litigation may be needed to address some issues.

Rachel Turow, Teva Pharmaceutical Industries Ltd. associate general counsel and head of US regulatory law and policy, said during...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Biosimilars

More from Biosimilars & Generics